Biotech

All Articles

Bicara, Zenas look for IPOs to push late-phase resources toward market

.Bicara Therapies and Zenas Biopharma have provided clean inspiration to the IPO market along with f...

Genentech to shut cancer cells immunology research team

.Genentech is going to shut its cancer immunology research study division, and unit mind and also po...

Kezar drops solid growth but to confirm its worth in phase 1 test

.Kezar Lifestyle Sciences is actually dropping its own dim period 1 sound growth medication as the b...

Acelyrin goes down izokibep, lets go 3rd of staff

.Regardless of izokibep maintaining its own newly found winning touch in the medical clinic, Acelyri...

Rivus' stage 2 obesity-related cardiac arrest test reaches endpoint

.Rivus Pharmaceuticals has actually plumped up the potential customers of its own fat-busting, muscl...

Ovid stops preclinical work, IV program after soticlestat fall short

.Ovid Therapy currently revealed final month that it was actually trimming its head count as the bus...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston Port

.Eli Lilly has opened a $700 million R&ampD facility in the Boston Seaport, enhancing its RNA and DN...

Boundless Bio produces 'moderate' layoffs five months after $100M IPO

.Simply five months after securing a $100 thousand IPO, Vast Bio is presently laying off some worker...

Halda's $126M will certainly evolve 'secure and also kill' growth medications

.The preliminary phases of oncology R&ampD may not be except interesting brand new techniques, as we...

Lykos 'regrets' not revealing research offenses with publisher

.Psychopharmacology has actually pulled three articles regarding midstage medical test information d...